BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 15533184)

  • 21. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
    Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
    J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
    Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
    Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Medicare hospital and physician data to assess breast cancer incidence.
    Warren JL; Feuer E; Potosky AL; Riley GF; Lynch CF
    Med Care; 1999 May; 37(5):445-56. PubMed ID: 10335747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients.
    Klabunde CN; Harlan LC; Warren JL
    Med Care; 2006 Oct; 44(10):921-8. PubMed ID: 17001263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of high technology imaging for surveillance of early stage breast cancer.
    Panageas KS; Sima CS; Liberman L; Schrag D
    Breast Cancer Res Treat; 2012 Jan; 131(2):663-70. PubMed ID: 21947679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment for breast cancer in patients with Alzheimer's disease.
    Gorin SS; Heck JE; Albert S; Hershman D
    J Am Geriatr Soc; 2005 Nov; 53(11):1897-904. PubMed ID: 16274370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying incident oral and pharyngeal cancer cases using Medicare claims.
    Mahnken JD; Keighley JD; Girod DA; Chen X; Mayo MS
    BMC Oral Health; 2013 Jan; 13():1. PubMed ID: 23280327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
    Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
    Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in the use of breast-conserving therapy for Medicare beneficiaries in Virginia: clinical, geographic, and hospital characteristics.
    Elward KS; Penberthy LT; Bear H; Swartz DM; Boudreau RM; Cook SS
    Clin Perform Qual Health Care; 1998; 6(2):63-9. PubMed ID: 10180123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal Cancer Identification Methods Among Kansas Medicare Beneficiaries, 2008-2010.
    Lai SM; Jungk J; Garimella S
    Prev Chronic Dis; 2015 Jul; 12():E107. PubMed ID: 26160293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional differences in the incidence and treatment of carcinoma in situ of the breast.
    Choi WS; Parker BA; Pierce JP; Greenberg ER
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):317-20. PubMed ID: 8722225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
    Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
    Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outpatient mastectomy and breast reconstructive surgery.
    Bian J; Krontiras H; Allison J
    Ann Surg Oncol; 2008 Apr; 15(4):1032-9. PubMed ID: 18165916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
    Lin CC; Virgo KS
    Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classifying Stage IV Lung Cancer From Health Care Claims: A Comparison of Multiple Analytic Approaches.
    Brooks GA; Bergquist SL; Landrum MB; Rose S; Keating NL
    JCO Clin Cancer Inform; 2019 May; 3():1-19. PubMed ID: 31070985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ability of Medicaid claims data to identify incident cases of breast cancer in the Ohio Medicaid population.
    Koroukian SM; Cooper GS; Rimm AA
    Health Serv Res; 2003 Jun; 38(3):947-60. PubMed ID: 12822920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
    McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
    Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.